Tower Research Capital (TRC)’s Adagene ADAG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,058
Closed -$4.44K – 5885
2026
Q2
$4.44K Buy
+1,058
New +$3.98K ﹤0.01% 4386
2022
Q3
– Sell
-3,627
Closed -$7K – 6014
2022
Q2
$7K Sell
3,627
-1,365
-27% -$4.13K ﹤0.01% 4755
2022
Q1
$17K Buy
4,992
+3,714
+291% +$23.4K ﹤0.01% 3670
2021
Q4
$10K Buy
+1,278
New +$13.1K ﹤0.01% 4528

Other funds holding ADAG

Tower Research Capital (TRC)'s ADAG Position: Q3 2026 in Review

Tower Research Capital (TRC) sold out of Adagene (ADAG) in Q3 2026, closing a stake of 1,058 shares — an estimated $4.44K sold.

Tower Research Capital (TRC) first reported a position in ADAG in Q4 2021 and held it in 4 quarters. The position peaked at $17K in Q1 2022. 38 funds tracked by Wall St. Rank hold ADAG as of Q3 2026.

  • Tower Research Capital (TRC) reported no remaining Adagene position as of Q3 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,058 Adagene shares in Q3 2026, an estimated $4.44K.
  • Tower Research Capital (TRC) first reported a position in Adagene in Q4 2021 and held it in 4 quarters.
  • Tower Research Capital (TRC)'s Adagene position peaked at $17K in Q1 2022.
  • 38 funds tracked by Wall St. Rank held Adagene as of Q3 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.